facebook-page-view
Advertisement

Vivimed Labs Ltd.

Premium
Kitara Capital spends $18.5 mn bottom-fishing listed firms

General

05 January, 2017

Kitara Capital spends $18.5 mn bottom-fishing listed firms

Mumbai-based private equity firm Kitara Capital Pvt Ltd, which invests mainly in publicly listed companies, has used part of the ......

Vivimed sells part of specialty chemical unit for $57.7M

Manufacturing

30 September, 2015

Vivimed sells part of specialty chemical unit for $57.7M

Drugmaker Vivimed Labs Ltd said on Wednesday it has agreed to sell some of its specialty chemical products to Clariant ......

Vivimed to sell part of specialty chemical unit for $57M

Manufacturing

14 September, 2015

Vivimed to sell part of specialty chemical unit for $57M

Hyderabad-based mid-size drugmaker Vivimed Labs Ltd, has received its board approval to sell a part of its specialty chemical business ......

Kitara Capital raising stake in Vivimed Labs

Healthcare

05 August, 2014

Kitara Capital raising stake in Vivimed Labs

Mumbai-based private equity firm Kitara Capital, which is focused on investing in public market firms, is raising its holding in ......

Vivimed Labs hit by decline in operating margins; PAT drops 23% but revenues up 25%

Healthcare

14 August, 2013

Vivimed Labs hit by decline in operating margins; PAT drops 23% but revenues up 25%

Vivimed Labs Ltd, which manufactures active pharmaceutical ingredients (APIs), finished dosage formulation (FDF) and retail branded formulation, saw its margins ......

Vivimed to acquire Actavis' formulations manufacturing facility in Tamil Nadu for $20M

Healthcare

06 August, 2013

Vivimed to acquire Actavis' formulations manufacturing facility in Tamil Nadu for $20M

Hyderabad-based Vivimed Labs Ltd, which manufactures specialty chemicals and pharmaceuticals, has struck a deal to acquire the solid oral dosage ......

Jacob Ballas picks 13.1% stake in Vivimed Labs on conversion of preference shares

Healthcare

22 March, 2013

Jacob Ballas picks 13.1% stake in Vivimed Labs on conversion of preference shares

NYLIM Jacob Ballas Fund III, managed by Jacob Ballas Capital India Pvt Ltd, has acquired 13.1 per cent stake in ......

PE-backed Vivimed buys Hyderabad-based Finoso Pharma for $2.8M

Healthcare

14 February, 2013

PE-backed Vivimed buys Hyderabad-based Finoso Pharma for $2.8M

Public listed Vivimed Labs has acquired Hyderabad-based Finoso Pharma Pvt Ltd in a cash cum stock deal worth Rs 15 ......